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Abstract 
 
Obesity and insulin resistance has increased in the last three decades among humans and cats and 
has been associated with an increase in the inflammatory response and oxidative stress in people.  
The purpose of this study was to determine if an increase in fat mass was associated with an 
increased inflammatory response and oxidative stress, leading to insulin resistance and abnormal 
insulin secretion.  Twenty cats of equal gender distribution were used for the study; 10 were fed 
a control diet (C) and 10 were fed the same diet containing an antioxidant mixture (AOX). The 
following parameters were measured at 0%, 10%. 30% and 60% weight increase: body mass 
index (BMI), girth, total fat, food intake, glucose and insulin concentrations before and after an 
intravenous glucose tolerance test, baseline cholesterol, HDL, triglyceride, non-esterified fatty 
acids (NEFAs), catalase, glutathione peroxidase, superoxide dismutase, interleukin-6 (IL-6), 
Interleukin-1 (IL-1), tumor necrosis factor alpha (TNF-alpha), respiratory exchange ration 
(RER), and heat production.     
Body mass index (BMI), girth, total fat, and energy intake increased significantly with increasing 
body weight.  There was no difference in glucose baseline concentrations as a result of body 
weight increase.  However, at 60% body weight increase the AUC for glucose increased 
significantly in cats fed AOX, indicating glucose intolerance.  A significant decrease was seen in 
insulin sensitivity with increasing body weight.  Baseline insulin concentrations and total AUC 
increased significantly with increasing body weight, BMI and girth indicating insulin resistance 
even at a 10% body weight increase.  Triglycerides and NEFAs increased significantly with 
increasing body weight, indicating a possible increase in VLDL and a decrease in lipoprotein 
lipase.  The enzyme activity of catalase, glutathione peroxidase, and superoxide dismutase did 
not change significantly with increasing body weight, indicating a lack of oxidative stress.  The 
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cytokines IL-6, IL-1, and TNF-alpha did not change significantly with increasing body weight, 
indicating no inflammatory response with increasing body weight.  The RER increased 
significantly at 30 and 60% body weight increase, indicating a decrease in fat oxidation.  A 
significant increase in heat production with increasing body weight was seen, indicating 
increased energy production, likely due to the increase in food intake.    
In conclusion, an increase in obesity does not elicit an inflammatory response in cats, despite the 
fact that it leads to insulin resistance even at a 10% body weight increase.  These results may in 
part explain the fact that obese cats do no exhibit atherosclerosis, hypertension or other signs of 
the metabolic syndrome observed in obese human subjects.   
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Chapter 1 Introduction 
 
   Obesity is a risk factor for diabetes in humans and cats and approximately 35-45% of cats are 
obese (Lund et al 2005).  Research has shown that obese cats have two defects: they are insulin 
resistant (Hoenig et al 2006 and 2007), and they show an abnormal insulin secretion pattern 
(Hoenig et al 2002).  Chronic oxidative stress is associated with obesity and insulin resistance in 
human subjects (Evans et al 2003).  However, it is not known whether oxidative stress causes 
obesity or whether obesity and insulin resistance cause oxidative stress. Oxidative stress occurs 
when there is an imbalance between free radicals and antioxidants.  Lipid peroxidation is a type 
of oxidative stress where lipids are oxidized into lipid radicals and is characterized by changes in 
enzyme markers such as catalase, superoxide dismutase, and glutathione peroxidase, among 
others.  During the postprandial phase, lipoproteins are prone to lipid peroxidation because they 
are enriched with triglycerides, and these oxidized lipoprotein particles are phagocytosed by 
macrophages via the scavenger receptor however, macrophages cannot metabolize the 
lipoproteins and therefore they accumulate inside the cytoplasm, resulting in atherosclerosis in 
people (Berliner et al 1995). The oxidized lipoproteins can also be chemotactic for monocytes 
and stimulate the expression of cytokines.  The stimulation of the inflammatory response has 
been shown to induce insulin resistance. We hypothesized that the increase in fat mass with 
obesity leads to an increase in oxidative stress in adipose tissue (Figure 1. step 1).  During 
postprandial lipemia, the delivery of dietary fats to adipose tissue is accompanied by the 
exposure of intestinal lipoproteins to increased oxidative stress, resulting in oxidative 
modification of plasma lipoproteins (Figure 1. step 2).  In the absence of effective antioxidant 
protection, excess oxidized modified lipoproteins may result in macrophage recruitment both in 
adipose tissue and peripheral tissues (Figure 1. step 3).  The accumulation of macrophages will, 
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in turn lead to the secretion of inflammatory cytokines and adipokines (Figure 1. step 4-7).  This 
proposed sequence would initiate the vicious cycle leading to insulin resistance, abnormal insulin 
secretion (Figure 1. step 4 and 6) and ultimately to diabetes.   
 
Figure 1:  Temporal development of insulin resistance.   
 
The goals of this study were: 
1.  To demonstrate that an increase in fat mass is associated with a shift in oxidative stress and to 
characterize the effect of increased fat mass on the modulation of the antioxidant protection 
enzyme as assessed by changes in the activity of antioxidant enzyme catalase, glutathione 
peroxidase, and superoxide dismutase.   
2.  To correlate the gradual changes in insulin resistance and in factors leading to insulin 
resistance:  free fatty acids, and inflammatory cytokines (IL-6, IL-1, TNF-alpha), were measured 
with the increase in fat mass. 
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3.  To demonstrate that the increase in fat mass is associated with a change in energy 
expenditure. 
4.  To demonstrate that supplementation of the diet with antioxidants can reduce oxidative stress.   
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Chapter 2 Literature Review 
Lipids 
   Lipids are composed of mainly carbon and hydrogen molecules with some oxygen containing 
functional groups.  They are hydrophobic and therefore insoluble in water.  Lipids circulate 
through the blood via molecules called lipoproteins that consist of phospholipids, cholesterol and 
proteins called apoproteins (Gibbons 2004).  Plasma lipoproteins are synthesized in the intestine 
and in the liver (Field 1995).  There are five main types of lipoproteins involved in lipid 
metabolism and they differ in the amount of triglycerides and cholesterol as well as different 
kinds of proteins.  The different kinds of lipoproteins are referred to as chylomicrons, very low 
density lipoproteins (VLDLs), intermediate density lipoproteins (IDLs), low density lipoproteins 
(LDLs), and high density lipoproteins (HDLs).  These lipoproteins are further divided into 
subclasses and differentiated by their particle size.  For example, cats and humans have two 
different kinds of HDLs, HDL2 and HDL3 however, cats have higher concentration levels of 
HDL than humans (Demacker 1988).  LDL particle sizes vary among humans (Scheffer et al 
1997) and two main particle sizes have been identified, large buoyant LDL particles and small 
dense LDL particles (Austin and Krauss 1986).  Cats have also shown differences in LDL 
particles depending on their body mass index (Jordan et al 2008).  In cats as in people, VLDLs 
are the largest lipoprotein, followed by LDL and HDL (Jordan et al 2008).  Even though cats 
have higher levels of HDL than humans do, they are still a good model for human comparison 
because their LDL composition is very similar and they both have the same sub-fractions of 
HDL (Demacker 1987).   
   The most biologically important groups of lipids in animals are fats, phospholipids, and 
steroids.  These lipids can be used for energy storage, structural components of cellular 
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membranes, and cell signaling.  Triglycerides are the most abundant lipids in animals and can 
come from diet, synthesis in the liver, and storage supplies in adipose tissue (Solomon et al 
2002).  They contain twice the amount of energy as carbohydrates and protein, i.e. 1 gram of fat 
yields 9 kcal (37kJ), 1 gram of carbohydrate yields 3.75 kcal (16kJ), and 1 gram of protein yields 
4k cal (17kJ) (Gibbons 2004).  Therefore, they are important storage units of energy. 
Exogenous Lipid Metabolism 
   Exogenous or dietary triglycerides pass through the stomach and are digested in the duodenum 
by pancreatic lipase into monoglycerides, diglycerides, glycerol and fatty acids (Solomon et al 
2002).  Bile helps in the digestive process by acting as an emulsifier and breaking down large 
masses of fat into smaller droplets, this allows the pancreatic lipase to attack it more easily.  
After triglycerides are broken down into smaller components, they combine with bile salts to 
form micelles and are then absorbed by epithelial cells lining the intestine.  In the epithelial cells, 
fatty acids and glycerol are re-esterified into triglycerides and packaged into lipoproteins. The 
lipoprotein formed from the components of the micelle in the epithelial cells is called a nascent 
chylomicron and is responsible for transporting exogenous triglycerides to other cells. (Cooper 
1997).  Nascent chylomicrons are mainly composed of triglycerides but contain some 
cholesterol, along with phospholipids and apoprotein B48 (Cooper 1997).  The nascent 
chylomicrons circulate through the lymphatic system and into the blood where they become 
‘mature” by receiving apoprotein C and apoprotein E from high density lipoproteins (HDLs) 
(Bauer 2004).  The chylomicrons circulate through the blood entering capillary walls of adipose 
and muscle tissue (Bauer 2004).  The apoprotein C present on the chylomicron activates an 
enzyme called lipoprotein lipase that is attached to the endothelial lining of capillaries via a 
heparin sulphate-proteoglycan (HSPG) (Braun 1992 and Mead et al 2002).  Lipoprotein lipase is 
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made in parenchymal cells and is then transported to the endothelial lining of capillaries.  
Activated lipoprotein lipase will break down the triglycerides in the chylomicrons into fatty acids 
and glycerol (Goldberg 1996).  The products of hydrolysis (fatty acids and glycerol) then diffuse 
into adipose or muscle cells and are either used for energy or stored for later use (Goldberg 
1996).  After chylomicrons interact with lipoprotein lipase they circulate back into the main 
blood stream where they interact with HDL again and donate back apoprotein C.  After this 
process, the chylomicron is considered a chylomicron remnant (Cooper 1997).  The chylomicron 
remnants contain a smaller amount of triglycerides than their precursor but have slightly higher 
levels of cholesterol esters and fat soluble vitamins (Cooper 1997).  Chylomicron remnants are 
endocytosed by the liver through a receptor-ligand interaction (Cooper 1997). The apoprotein 
B48 present on the remnant binds to its receptor on the liver cell which causes the liver cell to 
endocytose the remnant (Cooper 1997).  Apoprotein E present on the chylomicron remnant can 
also interact with LDL receptors on the liver cells and allow for endocytosis (Cooper 1997).  The 
materials that make up the chylomicron remnants are then used to synthesize new lipoproteins, 
called nascent very low density lipoproteins (VLDLs) (Field 1995).  Nascent VLDLs are 
different from chylomicrons because they contain a lesser amount of triglycerides and a slightly 
greater amount of cholesterol (Field 1995).  Lean cats have an even concentration of both large 
and medium VLDL particles (Jordan et al 2008).  During the synthesis of VLDL apoprotein B₁₀₀ 
is added.  When the synthesis of VLDL particles is complete, they leave the liver cell by 
exocytosis, and circulate through the capillaries to the main circulation where they receive 
apoprotein C and apoprotein E from HDL (Bauer 2004).  Once they receive those apoproteins 
from HDL they become mature. When they reach adipose tissue, apoprotein C activates 
lipoprotein lipase (Bauer 2004).  Again, the lipase metabolizes the triglycerides and the 
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components, i.e. glycerol and fatty acids diffuse into adipose cells where they are either used for 
energy or stored as triglycerides (Solomon et al 2002).  After VLDL has interacted with the 
lipase, it interacts with HDL to donate back the apoprotein C.  This process converts the VLDL 
to intermediate density lipoprotein (IDL).  VLDL remnants can also be metabolized to IDLs via 
another enzyme called hepatic lipase (Demacker 1988).  Hepatic lipase is synthesized in the liver 
but can be found in the adrenal glands and ovaries, and unlike lipoprotein lipase, hepatic lipase 
does not need to be activated by an apoprotein (Connelly 1999).  Similar to humans cats have a 
higher level of hepatic lipase than lipoprotein lipase (Demacker 1988).  One study found that 
hepatic lipase may contribute to lipid metabolism after a meal because when the enzyme was 
inhibited in the cat, there was an increase in plasma triglycerides and phospholipids (Demacker 
1988).   
   IDLs can interact with cells that have LDL receptors which bind to their apoprotein E with 
high affinity.  This results in further hydrolysis of the triglycerides present in IDLs and the 
lipoprotein now becomes low density lipoprotein (LDL).  Also, some IDLs will circulate directly 
to the liver where they are metabolized by hepatic lipase to LDLs (Connelly 1999).  The 
remaining LDLs continue to circulate through the blood stream binding to LDL receptors via 
their apoprotein B100 and delivering cholesterol to cells that need it. Cells in need of cholesterol 
to synthesize steroid hormones such as aldosterone, cortisol, or sex hormones, synthesize the 
LDL receptor and transport it to their surface membrane (Solomon et al 2002).  Any remaining 
LDLs not taken in by other cells are endocytosed by the liver where they are further degraded.  
In the cat, LDL particles can be separated into large, medium small, and very small particles 
(Jordan et al 2008).  Lean cats have been shown to have mainly large LDL particles (Jordan et al 
2008).  HDLs are primarily synthesized in the liver and are mainly composed of cholesterol and 
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small amounts of triglycerides. They are responsible for collecting excess cholesterol from 
peripheral cells, adding an ester to it using lecithin: cholesterol acyltransferase (LCAT) and 
transporting it to the liver for degradation (Solomon et al 2002).   
   Cats have been referred to as high ‘HDL animal’ because they possess greater concentrations 
of HDL cholesterol than LDL cholesterol (Ginzinger et al 1999 and Demacker et al 1987).  In 
cats, HDL particles can be separated into large, medium and small particles (Jordan et al 2008).  
It has been shown that lean cats have a higher concentration of medium HDL particles than small 
HDL particles (Jordan et al 2008).  During the exchange of apoproteins between chylomicrons 
and HDL, apoprotein AI is transferred from the chylomicron to HDL.  The apoprotein AI is 
responsible for activating LCAT, which synthesizes cholesterol esters from a carboxylate group 
on fatty acids and a hydroxyl group from cholesterol.   
   The process of returning excess cholesterol from peripheral cells to the liver is called reverse 
cholesterol transport (RCT) and cholesteryl ester transfer protein (CETP) is one of the molecules 
involved in this process (Fielding and Fielding 1995).  CETP helps transport cholesterol esters 
and triglycerides between lipoproteins (Murakami 1995).  For example, it transfers triglycerides 
from VLDL and LDL to HDL in exchange for cholesterol esters and vice versa (Murakami 
1995). CETP also exchanges the same molecule between lipoproteins, i.e. exchanging a 
triglyceride for another triglyceride or a cholesterol ester for another cholesterol ester between 
lipoproteins. CETP genes are found in liver, spleen, and adipose tissue and their expression is 
upregulated by the presence of cholesterol (McPherson 2008).  When VLDLs and LDLs are 
being cleared from the circulation by the liver at an efficient rate, CETP transfers cholesterol 
from HDL to the liver for biliary secretion (McPherson 2008).   
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   Hepatic lipase then hydrolyzes the triglycerides, cholesterol esters and phospholipids from the 
HDLs and converts HDLs into its different subfractions i.e. HDL2 and HDL3 (Connelly 1999, 
and Demacker 1988).  CETP also transfers cholesterol esters from HDL to the liver through a 
process called selective uptake, which does not involve HDL degradation (McPherson 2008).  A 
process different from selective uptake is the CETP transfer of cholesterol esters from HDL to 
LDL.  The LDL then binds to LDL receptors on hepatocytes and is endocytosed and degraded.  
In the liver, the cholesterol can be recycled and secreted with newly secreted lipoproteins or 
secreted with bile into the intestine and used to synthesize chylomicrons (Fielding and Fielding 
1995).  In contrast to humans, investigators have been unable to measure CETP activity in the cat 
(Ginzinger et al 1999 and Watson et al 1995).  When CETP activity is absent, cholesterol from 
HDL cannot be transferred to triglyceride-rich lipoproteins nor can triglycerides be transferred 
from triglyceride-rich lipoproteins to HDL (Ginzinger et al 1999).  
Endogenous Lipid Metabolism 
   When blood glucose levels are elevated, plasmas insulin concentrations increase concomitantly 
stimulating the uptake of peripheral glucose and decreasing the catabolism of glycogen reserves.  
Glucose is normally stored as glycogen in the liver and in muscle tissue through a process called 
glycogenesis.  However, when energy levels are high or too much food has been consumed some 
of the carbohydrates will get converted into fat and stored.  This is called endogenous 
triglyceride synthesis. The endogenous triglycerides synthesized from glucose in the liver and 
adipocytes are tripalmitin and tristearate.  Endogenous triglycerides synthesized in the liver 
circulate via VLDLs to adipose tissue, where they bind to lipoprotein lipase and release glycerol 
and fatty acids which after reesterification are stored as triglycerides for later use.   
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   When glycogen reserves in the liver are filled, glucose enters the pentose phosphate pathway, 
in order to be converted into fat and stored as energy for later use.  The fact that glucose is able 
to enter the pentose phosphate pathway and not the glycolytic pathway directly is due to the 
inhibition of isocitrate dehydrogenase by large levels of ATP and NADH produced in the 
mitochondria. The inhibition of isocitrate dehydrogenase increases the levels of mitochondrial 
citrate and isocitrate. This causes the citrate to diffuse into the cytosol via the tricarboxylate 
carrier and inhibit phosphofructokinase-1, thereby inhibiting glucose from entering the glycolytic 
pathway.  The excess citrate in the cytosol is also converted to oxaloacetate and acetyl CoA by 
the enzyme citrate lyase.  Acetyl CoA is needed for the synthesis of fatty acids.  Citrate activates 
acetyl CoA carboxylase, which is an enzyme that regulates fatty acid synthesis.  During the 
pentose phosphate pathway, glucose-6-phosphate dehydrogenase removes two hydrogens from 
the first carbon of the glucose-6-phosphate molecule to yield NADPH , which is a hydrogen 
carrier needed for fatty acid synthesis. The pentose phosphate pathway yields glyceraldehyde-3-
phosphate which then enters glycolysis to yield acetyl CoA.  The acetyl CoA combines with 
oxaloacetate to form citrate and diffuses back into the cytosol, where it is again broken down 
into oxaloacetate and acetyl CoA.  Acetyl CoA is converted to malonyl CoA by acetyl CoA 
carboxylase.  Malonyl CoA then reacts with acyl carrier protein (ACP) to form malonyl ACP.  
Malonyl then goes through more series of reactions to yield palmitate and stearate which are 
fatty acid chains that get added onto glycerol-3-phosphate.  After fatty acids and glycerol are 
synthesized in the liver from glucose they are esterified into triglycerides and packaged into 
VLDLs to be transported to adipocytes for storage.   
   Endogenous lipogenesis also occurs in adipocytes.  Insulin activates glucose transporter four 
(GLUT4) which transports glucose into the cell where it is immediately phosphorylated to 
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glucose-6-phosphate.  The glucose-6-phosphate then enters glycolysis and is converted to 
glycerol 3 phosphate to yield glycerol (backbone of triglyceride) or via pyruvate acetyl Co-A 
which is needed for the synthesis of fatty acids.  
  Lipid Metabolism in Starvation 
   In starvation, when energy levels are low and glycogen reserves are depleted, the triglycerides 
stored in adipose tissue are hydrolyzed by hormone sensitive lipase.   
During times of exercise or stress, the activity of hormone sensitive lipase is regulated by the 
catecholamines, epinephrine and norepinephrine, as well as insulin-antagonistic hormones such 
as cortisol and glucagon, among others.  Activated hormone sensitive lipase hydrolyzes 
triglyceride to monoacylglycerol.  Monoacylglycerol is then hydrolyzed by monoacylglycerol 
lipase to form glycerol and fatty acids.  These molecules diffuse into the circulation where fatty 
acids bind to serum albumin and circulate to the liver and skeletal muscles to be used for cellular 
respiration involving the following pathways: beta-oxidation pathway, the citric acid cycle, and 
the respiratory chain. The ATP which is produced by the metabolism of fatty acids provides 
energy for gluconeogenesis.  The hydrolyzed glycerol is used in gluconeogenesis to yield 
glucose. (Salaway 2004)  
Beta-Oxidation Pathway 
   In order for fatty acids to enter the mitochondria and become oxidized, they must first be 
activated in the cytoplasm to acyl-CoA by acyl-Co A synthetase.  Fatty acyl-CoAs are then 
transported to the mitochondria via the carnitine cycle.  Carnitine acyltransferase I is an enzyme 
located on the outer mitochondrial membrane and is responsible for transferring the acyl group 
from the cytosol to carnitine to yield acylcarnitine.  Acylcarnitine then diffuses into the 
mitochondrial intermembrane space and is transported to the matrix through the antiporter 
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carnitine-acylcarnitine translocase located in the inner mitochondrial membrane.  The enzyme 
carnitine acyltransferase II is also located in the inner mitochondrial membrane and transfers the 
acyl group back to Co A to yield acyl-CoA.  The substrate acyl-CoA can be metabolized in the 
beta-oxidation pathway to yield acetyl coenzyme A.  Acetyl CoA synthesized from fatty acids 
cannot be carboxylated to pyruvate and enter a reversed glycolysis reaction to yield glucose, 
because the pyruvate dehydrogenase and pyruvate kinase reactions are irreversible.  Instead, 
Acetyl CoA will enter the citric acid cycle to yield three more forms of energy molecules 
(NADH, FADH2, GTP) that will be used in the electron transport chain to yield ATP in oxidative 
phosphorylation. (Pelley 2007) 
Gluconeogenesis  
   The carbon skeletons needed for the synthesis of glucose come from glycerol.  After 
triglycerides are hydrolyzed to fatty acids and glycerol, glycerol is phosphorylated in the liver by 
glycerol kinase to glycerol 3-phosphate.  Glycerol 3-phosphate dehydrogenase then reduces the 
glycerol 3-phosphate to dihydroxyacetone phosphate (DHAP).  Dihydroxyacetone phosphate is a 
three carbon molecule, therefore, two molecules of DHAP are needed to make one molecule of 
glucose in gluconeogenesis and this process requires the energy from six ATP.  (Pelley 2007) 
Lipid Metabolism in Obesity 
   An increase in weight gain is a result of excess triglyceride storage in adipose tissue.  If energy 
intake continues to exceed energy expenditure obesity will ensue (Spiegelman et al 2001).  
Obesity is a risk factor for diabetes in both humans (Eckel et al 2005) and cats (Scarlett and 
Donoghue 1998) because it is associated with insulin resistance and glucose intolerance.  Obesity 
is also known to cause alterations in lipid and lipoprotein concentrations in people (Despress 
1990) and cats (Jordan et al 2008).  Some of the negative effects seen in lipid metabolism due to 
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obesity are similar between cats and humans and some are different (Hoenig et al 2003).  Obese 
individuals have elevated cholesterol, triglycerides, and apoprotein B, as well as higher levels of 
VLDLs, LDLs and lower levels of HDLs (Despress 1990). Newly obese cats unlike long-term 
obese cats and humans have been shown to have increased levels of HDL, which may be a 
protective mechanism against cardiovascular disease (Hoenig et al 2003).  Long term obese cats 
have higher levels of non-esterified fatty acids, triglycerides, and VLDLs and decreased levels of 
HDLs but unlike humans, hypertension and atherosclerosis has not been documented in the 
obese cat (Jordan et al 2008).  Although there is a decrease in HDL in obese cats, obese cats still 
have a higher concentration of HDL than in human subjects.  Research has shown that LPL in 
obese individuals is inhibited in adipose tissue but activated in muscle tissue (Phillips 1996 and 
Hoenig M, et al 2006).  When insulin is unable to activate its receptor, it is unable to activate 
LPL in adipose tissue and inhibit hormone sensitive lipase.  Inhibited LPL can no longer 
metabolize chylomicrons or VLDLs and activated hormone sensitive lipase continues to 
mobilize triglycerides from adipose tissue (Salaway 2004).  This interferes with the homeostasis 
of free fatty acids in the plasma and contributes to the high elevated levels of NEFAs seen in 
obese individuals and in cats.  Since these NEFAs are not properly stored in adipose tissue due to 
insulin resistance, they are stored in the liver and muscle (Saltiel and Kahn 2001).  The excess 
free fatty acids stored in liver and muscle tissue disrupt glycolysis, normal glucose uptake and 
lipid metabolism (Golay et al 1984).  In the liver, free fatty acids are esterified to triglyceride and 
transported to the blood via VLDLs, causing hyperlipidemia in obese individuals (Salaway 
2004).  To investigate the digestion and absorption of exogenous triglycerides in people with 
hyperlipidemia, subjects are given an oral fat load containing vitamin A.  Vitamin A is digested 
and absorbed similar to cholesterol and is transported in the plasma via chylomicrons.  Unlike 
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cholesterol, vitamin A is not recycled back into VLDL and is either bound to retinol-binding 
protein (RBP) and released into the plasma (Smith et al 1979) or stored in the liver (Blomhoff et 
al 1982 and 1984).  Therefore vitamin A is a good indicator of triglyceride rich lipoproteins of 
intestinal origin and is often use to trace the catabolism of lipoproteins.  Determining 
postprandial lipoproteins is important because these triglyceride rich proteins are thought to be 
atherogenic (Karpe et al 1999). 
   Recent studies have shown that particle size not the concentration of lipoproteins is associated 
with many of the co-morbidities of obesity.  These lipid alterations can cause changes in insulin 
secretion and insulin action in people but the mechanisms involved in its pathogenesis and 
progression to diabetes are still unknown (McGarry 2002).  In humans elevated levels of large 
particle VLDLs showed a decrease in insulin sensitivity (Goff et al 2005) and an increase in 
coronary artery disease (Freedman et al 1998).  The small HDL particles present in obese people 
(Goff et al 2005) result from the presence of elevated levels of triglycerides in HDLs, which 
leads to the activation of hepatic triglyceride lipase (Murakami et al 1995).  Hepatic triglyceride 
lipase breaks down HDLs into smaller particles and increases their clearance from the body 
(Murakami et al 1995).  The decrease in HDL interferes with the reverse cholesterol transport 
system and results in less cholesterol being transported from the periphery to the liver for 
elimination. Excess cholesterol remains in peripheral cells such as macrophages, or can remain 
in LDLs and be eliminated in the liver via hepatic LDL receptors where it will get excreted as 
bile.  However, this process of elimination from the periphery is not as efficient as reverse 
cholesterol transport.  The decrease in HDL also increases the risk of developing insulin 
resistance and heart disease in people (Garvey et al 2003).  Similar to HDL, increasing the 
concentration of triglycerides in LDLs increases their affinity for hepatic triglyceride lipase, 
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which metabolizes them into small dense LDL particles (de Graaf et al 1993).  Studies have 
shown that obese people (Goff et al 2005) and obese cats (Jordan et al 2008) have a greater 
concentration of small LDL particles and a lower concentration of large LDL particles.  In 
humans, these small LDL particles have been found to be associated with a decrease in insulin 
sensitivity (Goff et al 2005). They are also more susceptible for oxidation, have less affinity for 
the LDL receptor, and have a greater affinity for cell surface receptors (de Graaf et al 1993).  The 
smaller oxidized sub LDL particles damage the arterial walls because they can easily penetrate 
the endothelial lining and are therefore targets for macrophages (Blake et al 2002 and Sparrow et 
al 1989).  The oxidized LDL particles are phagocytosed by macrophages via the scavenger 
receptor however, macrophages cannot metabolize the lipoprotein, and therefore LDLs 
accumulate inside the cytoplasm, which leads to atherosclerosis (Berliner 1995).  Not only did 
long term obese cats show an increase in VLDLs and a decrease in HDLs, but more specifically 
they showed an increase in large and medium sized VLDL particles and the concentration of 
HDLs was mainly made up of small particles (Jordan et al 2008).  Although these findings were 
similar to those found in obese humans, atherosclerosis and cardiovascular disease has not been 
detected in the obese cat, suggesting other factors are involved in the disease progression (Jordan 
et al 2008). 
   Dietary fat content can also influence lipid metabolism and insulin resistance associated with 
obesity.  Saturated fatty acids (SFAs) increase plasma cholesterol, triglyceride, free fatty acid 
concentrations and decrease insulin sensitivity in humans (DeFronzo et al 1991) and in cats 
(Wilkins et al 2004).  In contrast, studies have also shown that people who consume 
polyunsaturated fatty acids (PUFAs) (DeFronzo et al 1991) and cats that are fed PUFAs (Wilkins 
et al 2004) have improved insulin sensitivity and lipid regulation because plasma triglycerides 
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and LDL decrease, and the HDL fraction increases.  It is believed that the beneficial effects of 
unsaturated fatty acids are derived from their ability to increase the expression of peroxisome 
proliferator activated receptor-γ (PPAR-gamma) (Luan et al 2001).    
 Lipid Peroxidation 
   In human subjects chronic oxidative stress is associated with obesity and insulin resistance 
(Evans et al 2003).  Oxidative stress occurs when there is an imbalance between free radicals and 
antioxidants (Madamanchi et al 2005).  Lipid peroxidation is a type of oxidative stress where 
lipids are oxidized into lipid radicals (Porter 1995).  Obese individuals show a faster rate of lipid 
oxidation when compared to lean individuals (Van Gaal et al 1998) because they have elevated 
lipid pools in adipose tissue and blood (Furukawa et al 2004).  Lipid radicals are not stable 
molecules because they contain unpaired electrons and are therefore highly reactive (Porter 
1995).  Lipid radicals like other free radicals disrupt normal cellular function and can lead to cell 
death.  The most common lipids that are oxidized are polyunsaturated fatty acids (PUFAs) 
because they have multiple double bonds and have highly reactive hydrogens (Porter 1995).  The 
double bonds present in PUFAs weaken the carbon-hydrogen bond next to them.  This weak 
carbon-hydrogen interaction makes the hydrogen more susceptible to react with free radicals 
(Porter 1995).  
   Lipid peroxidation increases dramatically in the postprandial phase (Musso et al 2006) because 
VLDL and LDL are enriched with lipids.  Lipid peroxidation occurs in three main steps, 
initiation, propagation, and termination (Bolland 1949 and Batemen 1954).  The first step, 
initiation, occurs when a polyunsaturated fatty acid reacts with a reactive oxygen species (ROS) 
such as, OH, forming a lipid radical and water (Bolland 1949 and Batemen 1954).  The lipid 
radical then proceeds to the next step, propagation, where it reacts with molecular oxygen to 
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generate lipid peroxyl-radical (Bolland 1949 and Batemen 1954).  This radical reacts with other 
polyunsaturated fatty acids or lipids in the cell membrane to create lipid hydroperoxide and more 
lipid radicals (Bolland 1949 and Batemen 1954).  This process is a chain reaction because it 
continues producing lipid radicals that destroy cell membranes resulting in even more lipid 
radicals.  The cell membrane is an extremely important part of the cell because it regulates 
permeability and contributes to cellular and molecular signaling (Solomon et al 2002).  A 
disrupted membrane can lead to cytotoxicity by inhibiting metabolic processes, as well as, 
altering ion channels resulting in abnormal cell signaling (Catala 2006).  Lipid radicals can also 
affect the membranes of mitochondria which can result in more ROS production due to electron 
leakage.  The increased production in ROS results in an increase in the synthesis of lipid radicals 
and the vicious cycle continues.   
   During propagation, large amounts of lipid hydroperoxide are created (Bolland 1949 and 
Batemen 1954).  Lipid hydroperoxide can react with reducing agents such as Fe++, producing 
lipid alkoxyl radical (Catala 2006).  This molecule like the lipid radicals contributes to the chain 
reaction and produces more lipid radicals.  Lipid hydroperoxide can also react with other reduced 
metals or ascorbate to produce reactive aldehyde products such as malondialdeyde (MDA) 
(Catala 2006).  MDA is the most abundant aldehyde product from lipid peroxidation and is often 
used as a biomarker for oxidative stress (Catala 2006).  Reactive aldehydes are stable molecules 
and can therefore sometimes diffuse from one cell to a different part of the body where they 
exert damaging effects (Catala 2006).    Reactive aldehyde products can also act as toxic second 
messengers in cells and add to the adverse effects of lipid peroxidation by affecting cell signaling 
and gene transcription (Catala 2006).   
 18 
   Linoleic acid is an essential fatty acid of all mammals for the production of other lipids and 
cholesterols (Solomon et al 2002).  Linoleic acid is a polyunsaturated acid and is therefore 
commonly oxidized in the lipid peroxidation process (Bolland 1949 and Batemen 1954).  It is 
oxidized at the methylene group (C11) in between the 9,10cis and 12,13cis double bonds (Porter 
1995).  Once linoleic acid is oxidized to a fatty acid radical, it readily reacts with oxygen to yield 
a lipid peroxyl radical.  The rate of lipid peroxyl radical synthesis depends on the amount of 
oxygen present and the reaction is very fast.  This reaction is reversible and is called beta 
fragmentation, because the bond between oxygen and the lipid radical is located at the beta 
position of the radical.  Peroxyl radicals can circulate in the body from a few milliseconds to 
seconds and can therefore react in different pathways (Marnett 1987).  If peroxyl radicals do not 
convert back to lipid radicals, they will react with other polyunsaturated lipids (Bolland 1949 and 
Batemen 1954).  This step in the reaction is the slowest (Porter 1995) and contributes the most to 
the chain reaction by reacting with cell membranes which are extremely susceptible to damage 
by lipid radicals because they are made up of polyunsaturated fatty acids. 
   Lipid radicals are only terminated when they react with another lipid radical or when 
antioxidants, such as, superoxide dismutase, catalase, and peroxidase reduce the molecule to a 
stable form (Bolland 1949 and Batemen 1954).  Antioxidants convert peroxyl radicals to lipid 
hydroperoxide, therefore terminating the ability of the peroxyl radical to interact with other lipids 
and creating more free radicals (Bolland 1949 and Batemen 1954).  Dietary antioxidants consist 
of tocopherols, ascorbate, carotenoids, thiols, polyphenols, and other micronutrients and have 
been shown to reduce oxidative stress.  For example vitamin E donates hydrogens readily to free 
radicals and still remains stable and un-reactive (Bowry 1999). Human adipocytes exposed to 
oxidative stress and then treated with antioxidants showed a decrease in ROS and an increase in 
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proliferation and viability (Roche et al 2009).  Consumption of a diet rich in flavonol reduced 
DNA damage in lymphocytes that were exposed to an oxidative challenge ex vivo (Lean et al 
1999).  Patients with type 1 and 2 diabetes given a diet supplemented with α-lipoic acid, vitamin 
E, or selenium for 12 weeks, showed a decrease in lipid peroxidation (Ziegler et al 1996).  
Although antioxidants are beneficial, they do not react as fast as molecular oxygen or lipid 
radicals do and therefore if there is an increase in free fatty acids as seen in obesity, then the 
detrimental effects of lipid peroxidation outweigh the beneficial effects of antioxidants.  
Research has also shown conflicting data on the debate of potential health benefits of 
antioxidants.  The number of assays available on the market for antioxidants and indicators of 
oxidative stress is limited and they often lack specificity and are poorly validated (Hermans et al 
2007). Diabetic and non diabetic cats fed Purina Dietetic Management (DM) cat food containing 
high levels of vitamin E for 8 weeks did not show a difference in MDA or in reduced or oxidized 
glutathione (GSH:GSSG) before or after the study (Webb 2009).  Another study looking at 
oxidative stress and kidney failure found that cats with renal insufficiency had higher levels of 
MDA compared to healthy cats however, even after supplementation with antioxidants for four 
weeks, the MDA levels remained unaltered (Yu and Paetau-Robinson 2006).  
Glucose Metabolism in Lean Subjects 
   Postprandially, when glucose levels are high, glucose enters pancreatic beta cells via glucose 
transporter two (GLUT2).  GLUT2 has the highest Km for glucose of all the glucose 
transporters.  In the beta cell the glucose undergoes glycolysis and is metabolized to pyruvate.  
Pyruvate is converted to acetyl co A and enters the citric acid cycle (CAC) to yield the electron 
carrying molecules NADH, FADH2, and GTP.  These reduced molecules donate their electrons 
to the electron transport chain (ETC) resulting in oxidative phosphorylation and the synthesis of 
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many ATP molecules.  ATP binds to ATP-dependent K channels located in the beta cell 
membrane, causing them to close and resulting in depolarization of the beta cell.  The 
depolarization opens voltage-gated calcium channels allowing calcium to enter into the cell.  The 
increase in intracellular calcium concentration activates the enzyme phospholipase C which 
cleaves phosphatidyl inositol 4, 5-bisphosphate (PIP2) into inositol trisphosphate (IP3) and 
diacylglycerol (DAG).  IP3 binds to receptor proteins in the endoplasmic reticulum, allowing for 
release of calcium from the ER via IP3 gated channels.  The influx of calcium stimulates 
secretory vesicles to fuse with the cell membrane, and release insulin into the extracellular fluid.        
   Insulin binds to its receptor on different tissues and activates insulin-receptor substrate (IRS), 
inducing an intracellular signaling cascade and cellular effects.  The primary action of insulin is 
to stimulate glucose uptake in insulin sensitive tissues by increasing the movement of glucose 
transporters to the cell surface.  The main glucose transporters involved in peripheral glucose 
uptake into tissues are GLUT4 and GLUT1.  GLUT1 is insulin-insensitive and is located in the 
plasma membrane. It has a low km and operates primarily at basal glucose concentrations.  
GLUT1 can be found in most tissues, including, brain, red blood cells, blood brain barrier, as 
well as muscle and adipose tissue.  The insulin-sensitive GLUT4, however, responds to insulin 
by translocating to the cell membrane where they increase glucose uptake 10-40 fold 
(Hashiramoto and James 2000). Insulin sensitive GLUT4 is the primary transporter found in 
muscle and adipose tissue.  
   In adipose and muscle tissue, glucose enters the glycolytic pathway and CAC and ETC to yield 
energy molecules.  In adipose tissue, glucose can also be converted to fatty acids and stored as 
triglycerides or in muscle tissue glucose can be stored as glycogen.  When glucose levels are 
low, the hormone glucagon is released from alpha cells in the pancreas which stimulates the liver 
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to break down glycogen and release glucose molecules into the circulation.  After glycogen 
reserves have been depleted, the liver synthesizes glucose from non-carbohydrates through 
gluconeogenesis.  
Glucose Metabolism in Obese Subjects 
   As animals and people become obese, insulin becomes less effective in its ability to stimulate 
glucose uptake in cells of the liver, skeletal muscle and adipose tissue. In people, insulin also 
becomes less effective in suppressing hepatic glucose output (Defronzo 1991; Porte 1991; 
Paquot et al 2002). The response to this defect is an increase in the output of insulin which 
results in hyperinsulinemia.  A 50% increase in body mass index (BMI) in cats causes about a 
60% increase in insulin resistance (Hoenig et al 2006).  Insulin resistance has been well 
documented in the cat (Hoenig et al 2007; Wilkins et al 2004); however obese cats usually show 
fasting euglycemia. This is explained by the fact that obese cats maintain hepatic insulin 
sensitivity despite peripheral insulin resistance as shown in a recent study by Kley et al (2009).  
In contrast, obese humans with high insulin levels showed an increase in endogenous glucose 
production, indicating hepatic insulin resistance (Weyer et al 1998).   
   Research has shown that in the beginning stages of type 2 diabetes glucose transporter activity 
is impaired in muscle tissue and this has also been shown in individuals who have altered lipid 
metabolism (Rothman et al 1995).   In the normal state, insulin stimulates glycogen synthesis and 
increases glucokinase activity. When insulin action is impaired, glycogen synthesis is decreased 
and glycogenolysis is activated resulting in the release of glucose from the liver thus contributing 
to the hyperglycemic state.  Due to hyperglycemia, GLUT2 gene expression is increased in islets 
and liver (Tiedge et al 1991).  In muscle tissue a decrease in insulin sensitivity, leads to an 
increase in fatty acid oxidation in order to synthesize energy yielding molecules.  The products 
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from beta-oxidation (acetyl CoA and NADH) inhibit pyruvate dehydrogenase, an enzyme that 
regulates glycolytic metabolites into the Krebs cycle.  In the absence of activated pyruvate 
dehydrogenase, the glycolytic metabolites are converted into lactate and alanine and metabolized 
in the liver during gluconeogenesis.  Therefore, fatty acid oxidation in muscle tissue contributes 
to the hyperglycemia seen in obese individuals. (Salaway 2004)  In adipose tissue the down 
regulation in GLUT4 decreases the activity of glycolysis and decreases the synthesis of glycerol 
3-phosphate.  Without the formation of glycerol 3-phosphate, there is no other molecule 
available for the re-esterification of the fatty acids formed by hormone sensitive lipase.  As a 
result, the free fatty acids diffuse into the blood circulation.  (Salaway 2004)  Obesity in cats is 
also characterized by a decrease in the activity and expression of lipoprotein lipase in adipose 
tissue, contributing to the increase in free fatty acids in blood (Hoenig et al 2006).  Obese cats 
have low GLUT4 expression in both muscle and adipose tissue, whereas the expression of 
GLUT1 is not different between lean and obese cats (Brennan et al 2004).  The onset of this 
reduction is early and arises before any fasting hyperglycemia is evident (Brennan et al 2004). It 
is hypothesized that this impairment in GLUT4 transporter is due to a defect in the transport 
vesicle responsible for delivering the transporter to the cell membrane (Brennan et al 2004).  The 
reduced expression of GLUT4 in obese cats could serve as an early marker for the progression to 
diabetes.  Other studies have shown that GLUT1 transporter is insulin insensitive because the 
transporter is already localized in the cell membrane and therefore no significant change was 
seen in the expression of GLUT1 in obese cats (Hansen et al 1998 and Brennan et al 2004). 
Inflammatory Mediators, Cytokines, and Lipid Metabolism 
   The immune and endocrine systems are linked in many ways with (Wellen and Hotamisligil 
2005).  For example, the inflammatory response initiated by the immune system depends on 
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energy metabolized from lipids to fight off diseases, and therefore it activates catabolic pathways 
and inactivates anabolic pathways such as, the insulin signaling pathway (Wellen and 
Hotamisligil 2005).  The two systems are also connected because the primary cells involved in 
both systems, i.e. adipocytes and macrophages, function in similar ways and respond to the same 
hormones, cytokines, and other signaling proteins. Like adipocytes, macrophages can store 
lipids; however, they become foam cells that lead to atherosclerosis (Wellen and Hotamisligil 
2005).  When circulating in the appropriate environment, preadipocytes can be phagocytic, 
display antimicrobial properties, and differentiate into macrophages (Cousin et al 1999). These 
cells also synthesize the same proteins, such as, PPARgamma, TNF-alpha, IL-6, and matrix 
metalloproteinases (MMPs) (Wellen and Hotmisligil 2004 and Hotmisligil et al 1993).   
   A metabolic imbalance such as obesity will result in imbalance in the immune system and lead 
to inflammatory diseases (Wellen and Hotmisligil 2004).  Recent findings have shown that 
obesity is characterized by chronic low level inflammation in adipose tissue (Xu et al 2003), 
possibly resulting from the accumulation of macrophages in adipose tissue (Weisberg et al 
2003).  It is hypothesized that macrophages stimulate the synthesis of inflammatory mediators 
either alone or synergistic with adipocytes, and macrophages may be an important factor in the 
development of insulin resistance (Wellen and Hotmisligil 2004).  Similar to macrophages, 
metabolic stresses in obesity, such as endoplasmic reticulum (ER) stress and increased ROS 
production, can activate inflammatory signaling pathways and contribute to insulin resistance 
(Ozcan et al 2004 and Lin et al 2005).  Inflammatory mediators disrupt insulin signaling by 
inhibiting the insulin signaling cascade (Wellen and Hotmisligil 2004).   Some of these 
inflammatory mediators include the cytokines IL-6 and IL-1, and the adipokines adiponectin, 
leptin, and tumor necrosis factor (TNFalpha).  It has been shown that short term obesity and 
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dietary fatty acid composition does not affect immune function in cats (Jaso-Friedmann et al 
2008).  
IL-6 and IL-1 
   IL-6 is a cytokine with many functions and is involved in immune and inflammatory responses 
(Cahill and Rogers 2008).  This cytokine can be synthesized by different cells including, 
adipocytes, activated leukocytes, fibroblasts, and endothelial cells.  Research has shown that 
30% of circulating IL-6 is synthesized from adipocytes (Mohamed-Ali et al 1997) and this 
percentage increases with obesity and decreases with weight loss (Mohamed-Ali et al 1997).  
The increase in IL-6 in obesity may help contribute to the state of chronic, low-grade 
inflammation. IL-6 secreted from adipocytes stimulates hepatic triglyceride secretion and 
induces hepatic gluconeogenesis contributing to the hyperglycemic state seen in obesity related 
type 2 diabetes.  Furthermore, IL-6 decreases insulin sensitivity and lipoprotein lipase activity in 
adipocytes and increases lipolysis and the synthesis of leptin.  These findings indicate that IL-6 
may play a role in the pathogenesis of insulin resistance in obesity (Lazar 2005).  In contrast, in 
vitro experiments have revealed that IL-6 increases GLUT4 translocation, glucose uptake, and 
fat oxidation in muscle and fat cells (Carey et al 2006).  Research has also shown that when 
humans were infused with IL-6 during a hyperinsulinemic-euglycaemic clamp they had 
enhanced insulin action (Carey et al 2006).  Therefore, IL-6 may not always be one of the 
culprits involved in type 2 diabetes.   
   IL-1 is one of the primary proinflammatory cytokines involved in an immune response and 
induces fever, lymphocyte activation, and acute phase protein synthesis (Stylianou and 
Saklatvala 1998).  It is synthesized in many immune cells including, macrophages, dendritic 
cells, B cells, and T cells (Dinarello 1991).  IL-1 increases during hyperglycemia, regulates 
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insulin secretion, is involved in central leptin action (Wellen and Hotamisligil 2005), and induces 
expression of IL-6 (Cahill and Rogers 2008).  IL-1 receptor antagonist is a protein that competes 
with IL-1 for the same binding site on the IL-receptor and therefore blocks the effects of IL-1 
(Dinarello 1998).  IL-1 receptor antagonist is synthesized in human white adipose tissue and is 
upregulated in obese individuals (Juge-Aubry et al 2003).  Mice administered IL-1 receptor 
antagonist showed a decrease in the effectiveness of leptin on food intake and body temperature 
(Luheshi et al 1996).    Research has also shown that mice lacking the IL-1 receptor had 
increased body weight and food intake and showed decreased leptin sensitivity, fat utilization, 
and locomotor activity when compared to wild-type mice (Garcia et al 2006).   These studies 
indicate that some of the actions of leptin on food intake and body temperature are mediated by 
IL-1, however, in obese individuals the leptin receptor becomes defective.   
TNF alpha 
   TNF-alpha is a proinflammatory cytokine that is released from macrophages, mast cells, 
neuronal cells, fibroblasts, and adipocytes.  It acts by inducing hepatic C-reactive protein 
synthesis and IL-6 expression (Hotamisligil et al 1993).  TNF-alpha is also known to cause the 
release of monocyte-chemoattractant protein-1 (MCP-1) from preadipocytes.  MCP-1 attracts 
macrophages to adipose tissue, which results in the release of more inflammatory mediators and 
contributes to insulin resistance (Wellen and Hotamisligil 2005).  TNF-alpha was the first 
cytokine discovered to show a link between inflammation and obesity (Hotamisligil et al 1993).  
Investigators found that this cytokine was over-expressed in the adipose tissue of obese rodents 
(Sethi and Hotamisligil 1999), obese cats (Hoenig et al 2006), and obese humans (Hotamisligil et 
al 1993).  Furthermore, weight loss in obese humans leads to a decrease in expression of adipose 
TNF-alpha (Hotamisligil et al 1995).  TNF-alpha contributes to insulin resistance by inhibiting 
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insulin receptor substrate through serine phosphorylation (Hotamisligil et al 1996).  Serine 
phosphorylation decreases the interaction between insulin receptor and IRS-1 and decreases 
tyrosine phosphorylation in response to insulin (Hotamisligil et al 1996).  TNF-alpha also 
inhibits the effects of lipoprotein lipase,contributing to the increase in free fatty acids in obesity.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 27 
Chapter 3 Materials and Methods 
Animals and Diets 
   Twenty lean and neutered domestic shorthair cats (10 males and 10 females) were used in this 
study.  Cats were maintained at the University Of Illinois College Of Veterinary Medicine 
Animal Care Facility under standard colony conditions.  They were housed individually in cages 
and were given free access to water.  Animal studies were approved by the University of Illinois 
Animal Care and Use Committee and conducted in accordance with guidelines established by the 
Animal Welfare Act and the National Institutes of Health Guide for the Care and Use of 
Laboratory Animals.  Cats were determined healthy based on the results of physical examination 
and clinical laboratory data.  All cats were socialized daily and were accustomed to daily 
handling.   
   Prior to the beginning of this study all cats had been fed a commercial diet (Purina ProPlan, 
Nestle Purina, St. Louis, MO) for 8 months.  The cats were equally and randomly assigned to 
one of two food groups, control diet C (10 cats; 5 males and 5 females) or diet AOX (10 cats; 5 
males and 5 females).  The composition of the diets is listed in Table 1. Food intake was 
measured daily, and the cats were weighed once weekly.  
Study Design 
   Time 0 refers to the time of experiments when all cats were lean; time 10, 30, and 60 refers to 
the time of experiments when cats had increased their body weight by 10, 30, and 60%, 
respectively. The increase in weight was achieved by allowing increased food intake.  Indirect 
calorimetry measurements were performed on all cats one week prior to other testing.  An 
intravenous glucose tolerance test (IVGTT) was performed one week after indirect calorimetry 
measurements were performed. The cats were allowed to rest for one day and on day 3, Mazola 
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oil containing vitamin A was given orally by syringe and blood samples were taken at various 
intervals for 6 hours.  Nuclear magnetic resonance imaging was performed within one week after 
completion of the lipid challenge test.  
Sample Processing 
   To allow for blood sampling, intravenous catheters were placed into the jugular vein after 
tranquilization of the cats with 1-2 mg/kg telazol subcutaneously.  The catheters were placed 15-
18 hours before each testing period. Catheter patency was maintained by injection of 0.5ml of 
0.38% sterile citrate flush (citric acid, trisodium salt dehydrate, Sigma Co., MO) every 8-14 
hours.  All blood samples were collected through the jugular catheter into tubes containing 
EDTA. The blood was placed on ice immediately and centrifuged at 405 x g for 15 minutes.  The 
plasma was stored at -80°C until assayed. For measurements of catalase, glutathione peroxidase, 
and superoxide dismutase   the red blood cells (RBC’s) were washed four times with 0.9% NaCl 
and they were lysed with cold double distilled water as described by the manufacturer (Cayman 
Chemical Ann Arbor, MI) .  
Indirect Calorimetry 
   The width of the Plexiglas calorimetry chambers was 20 in. and the height was 16 in. The 
chamber operated at a flow of 5 liters per min.  A silica drying column was used to equilibrate 
the humidity.  Respiratory exchange ratio, heat, and flow of air through the calorimetry chamber 
(liters per minute) were measured using an open-circuit Oxymax System (Software, version 5.0, 
Columbus Instruments, Columbus, OH).  System settle time for each chamber was equal to 60 s, 
and system measure time for each chamber was equal to 30 s. Calibration of the calorimeter 
chambers was performed daily using standard gas mixtures against known calibration gas 
standards. Room temperature was maintained at 25±1 ◦C. The cats were fasted overnight and 
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indirect calorimetry was performed for 2 h to determine baseline RER and heat production in 
conscious cats.  
The following calculations were used:   
RER =litersCO2 produced/ liters O2 consumed  
Heat production (kcal) = 3.82 × litersO2 consumed + 1.15 × litersCO2 produced.     
Heat/metablic body size (HMBS) = heat production (kcal/kg)/(body weight)0.75 
Liters O2 consumed was determined from the accumulated O2 at a given time minus O2 
consumed at time 0. Liters CO2 consumed was determined from the accumulated CO2 at a given 
time minus CO2 consumed at time 0. 
Intravenous Glucose Tolerance Test (IVGTT) 
   Intravenous glucose tolerance tests were performed in all cats as follows.  Food was withheld 
for 12 to 14 hours before testing. Two baseline samples were collected for measurement of 
insulin, and glucose. These 2 baseline samples were averaged. A glucose bolus (50% dextrose, 
w/v) of 0.5g/kg body weight was then injected and blood samples were taken at 5, 10, 15, 30, 45, 
60, 90, 120, 180 min for the measurements of glucose and insulin.   
Postprandial Analysis of Lipoproteins  
   In order to analyze the oxidative modification of lipoproteins postprandially, cats were given 
Mazola oil (1.5ml/kg) containing vitamin A (100 I. U./kg body weight) orally by syringe.  
Vitamin A served as a marker for intestinally derived chylomicron particles.  Blood samples 
were taken before and 30, 60, 120, 180, and 360 minutes after oral administration of Mazola oil.  
Non-esterified fatty acids, cholesterol, triglycerides, and HDL were measured following 
fractionation by fast protein liquid chromatography (FPLC) (Innis-Whitehouse et al 1998).   
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   Susceptibility of VLDL and LDL to oxidative modification were assessed by monitoring the 
continuous formation of conjugated dienes (Esterbauer et al 1991).  Indices of oxidative stress 
were assessed by measuring asymmetric dimethylarginine (ADMA), an endogenous competitive 
nitric oxide synthase inhibitor, with high performance liquid chromatography (HPLC) and 
nitrotyrosinated-protein was measured by ELISA (Cell Sciences, Canton, MA).  These tests were 
preformed in the laboratory of Dr. Anh Le at Emory University and results were not part of this 
master’s thesis.   
Enzyme Assays  
   The following assays were performed on samples taken at baseline during the IVGTT: The 
activity of catalase and glutathione peroxidase was measured using commercially available kits 
from Cayman Chemical (Ann Arbor, Michigan).  The glutathione peroxidase samples were 
diluted 1:200 with sample buffer from the kit prior to assay.  The catalase samples were diluted 
1:2000 with sample buffer from the kit prior to assay.  After the necessary dilutions, all assays 
were performed following the manufacturer’s directions.   The activity of superoxide dismutase 
(SOD) in lysed RBC’s was measured using a commercially available kit from RANDOX 
(Oceanside, CA).  The samples were diluted 1:200 using RANSOD diluent prior to assay.  For 
the analysis of superoxide dismutase in the plasma, an intravenous injection of heparin (100 
units/kg body weight) was given to each cat and blood samples were taken before and 2, 10, and 
15 minutes post heparin injection.   Heparin released superoxide dismutase was measured using a 
commercially available kit from Cayman Chemical (Ann Arbor, Michigan).  All enzyme assays 
were assayed within 4 weeks of sample collection. The recovery from RBC’s and plasma was 
assessed by the addition of known quantities of standard to plasma samples. All samples were 
tested in duplicate. The standard curve for serial dilutions of plasma from cats was observed to be 
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parallel to the standard curve provided by the manufacturer for all assays. Addition of 4 
concentrations of the standards provided in the catalase kit to feline plasma resulted in mean ± 
SE recovery of 97 ± 1.1%. The assay had a working range of 2-34nmol/min/ml.  Addition of 5 
concentrations of the standards provided in the SOD (RBC) kit to feline plasma resulted in mean 
± SE recovery of 91± 0.5%.  The assay had a working range of 0.168-4.68 units/ml.  Addition of 
5 concentrations of the standards provided in the SOD (plasma) kit to feline plasma resulted in 
the mean ± SE recovery of 94± 1.4%.  The assay had a working range of 0.025-0.25 units/ml. 
Inflammatory Cytokines and Adipokines 
   IL-6, IL-1, and TNF alpha were also measured in baseline samples from the IVGTT following 
manufacturer instructions for feline ELISA kits using feline standards (R and D systems 
Minneapolis, MN).   
Other Assays    Glucose measurements were performed using colorimetric glucose oxidase 
method (Genzyme Diagnostics, Charlottetown, PE Canada).  Insulin measurements were 
performed as validated and described previously (Hoenig and Ferguson, 1989)  
Magnetic Resonance Imaging  
  Fat mass was determined with nuclear magnetic resonance as previously described (Hoenig et 
al 2007).  MRI measurements were performed in all cats after injection of tiletamine HCL and 
zolazepam HCL  (2-4mg/kg subcutaneously, Fort Dodge Animal Health, Fort Dodge, IA).  All 
cats were investigated on a Siemens Magnetom Trio 3T horizontal spectroscopy and imaging 
system with a 16 X 16-cm field of view.  Magnetic resonance imaging was performed at 0, 10, 
30, and 60% body weight increase.  The slice thickness was 3mm with 0.3125 X 0.3125 points.  
Repetition time (Tr) was 0.4 s, and echo time (TE) was 9.4 ms.  The data of the total fat mass 
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were analyzed with the Amira 5.3 program from Visage Imaging (San Diego, CA).  Only slices 
where both kidneys were visible were analyzed.   
Statistical Analysis 
     The statistical model-based data analysis was carried out using a so-called non-linear mixed 
effects (NLME) population approach, which consists of fitting all experimental data collected in 
all cats simultaneously while considering the possible effect of covariates, such as time of study, 
gender, diet, BW, and measured factors associable to insulin resistance.  The NLME method is 
the most dependable statistical approach, especially in small cohorts, to characterize time 
functions of repeated measurements in terms of population average model parameters and 
between-animal variability that can be in part random and in part predictable through covariates.  
The significance level required for including a covariate in the population model was, in general, 
P=0.05.   A repeated measures analysis of variance was used to compare parameters between 
groups and time-points to account for repeated measurements over time of the same individuals 
and an unstructured covariance structure was assumed (p-value of < 0.05).  
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Chapter 4 Results 
Body Weight, BMI, Girth, Energy Intake, and Total Fat 
   The weight, BMI, girth, energy intake, and total fat of the cats are shown in Table 2.  There 
were no gender or diet differences and all parameters were significantly lower in cats at 0% body 
weight increase compared to cats at 60% body weight increase (p < 0.0001).  Total fat was 
highly correlated with BMI (Figure. 2A), body weight (Figure. 2B), and girth (Figure. 2C).  
There was also a significant correlation between BMI and body weight (Figure. 3A) and girth 
(Figure 3B) and between girth and body weight (Figure. 3C).  Food intake correlated 
significantly with BMI (Figure. 4A), body weight (Figure. 4B), and girth (Figure. 4C). 
Glucose 
   The results for baseline (mg/dl) and area under the curve (AUC; g/dl per 180min) 
concentrations of plasma glucose are shown in Table 3. There was no significant difference 
between the baseline glucose concentrations of cats fed C or AOX.  The mean (±SEM) baseline 
concentration of glucose in cats at 0% body weight increase was (89.2 + 3.5) and in cats at 60% 
body weight increase was (87.4 + 2.2).  The total AUC for glucose was significantly higher in 
cats fed AOX at 60% (25.6 + 1.2)  at 30% (23.6 + 0.5) body weight increase (p < 0.0331).     
Insulin 
   The insulin secretion pattern in response to glucose is shown in Figure 5.  Diet had no effect on 
insulin concentrations.  Baseline insulin concentrations (pmol/L) increased significantly with 
increasing body weight (Table 4; p < 0.024 for all) and was highly correlated with BMI (Figure. 
6A), body weight (Figure. 6B), and girth (Figure. 6C).  The total AUC for insulin also 
significantly increased with increasing body weight (p < 0.001). The insulin concentrations were 
significantly different from baseline at 120 and 180 min (Table 4; p < 0.025 for both).  Insulin 
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concentrations at 120 and 180 min after glucose administration increased significantly with 
increasing body weight (Table 4; p < 0.043 for all). The total AUC for insulin was highly 
correlated with BMI (Figure. 7A), body weight (Figure. 7B), and girth (Figure. 7C).  
Lipid Analysis 
   Diet had no effect on plasma baseline cholesterol, triglyceride, HDL, and NEFA.  Baseline 
cholesterol and total AUC for cholesterol and HDL did not change significantly with increasing 
body weight.  An increase in body weight significantly increased triglyceride concentrations (p < 
0.023 for all).  A significant difference was also seen in NEFA concentration when body weight 
increased to 30 and 60% compared to 0% (Table 5). 
Enzyme Assays 
   The results for catalase, glutathione peroxidase, and superoxide dismutase activity in red blood 
cells (RBCs) are shown in Table 6.  Diet had no effect on enzyme activity and there was no 
significant difference among the cats with increasing body weights.  The results for baseline and 
AUC heparin-releasable superoxide dismutase (SOD) activity are shown in Table 7.  There was 
no effect of diet on heparin-releasable SOD and there was no significant difference among the 
cats with increasing body weight.      
Cytokine and Adipokine Assays 
   The results for plasma IL-6, IL-1, and TNF-alpha are shown in Table 8.  Diet had no effect on 
cytokine or adipokine concentrations and there was no significant difference among the cats with 
increasing body weight.   
Indirect Calorimetry  
   Diet did not have an effect on the baseline respiratory exchange ratio (RER) or on baseline heat 
production in cats and the results were combined.  The RER was significantly higher at the 30 
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and 60% body weight increase (Table 9.)   Baseline heat production in cats increased 
significantly with increasing body weight.   
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Table 1:  Composition of Diets   
  
 Control (C) Antioxidants (AOX) 
 Nutrient Composition g/100g Nutrient Composition g/100g 
Moisture 7.20 6.56 
Protein 45.20 48.10 
Fat 18.3 18.5 
Carbohydrate 21.13 18.42 
Crude fiber 0.71 0.813 
Ash 7.46 7.61 
Metabolizable energy, kcal/g 3.9 3.87 
 Components % Components % 
PFC _ 2061     _R91 2.0 2.0 
Soy_Protein  
Isolate _Bagged 
5.325 5.325 
L_Lysine                                          0.033 0.033 
Taurine 0.083 0.083 
Potassium Chloride 0.610 0.630 
Wheat Gluten Vital Bulk 8.033 12.867 
Corn Gluten Meal 60 16.639 16.637 
Vit Super Prem 0.050 0.050 
Wheat Flour Second Clear or 
Better                 
17.192 12.867 
B_Carotene  
10_Blend BASF                          
 0.133 
Chicken Whole Carcass and 
Parts                    
18.276 18.273 
Fish Meal                                           2.662 2.662 
Vitamin E 50 0.020 0.033 
Poultry By Product Meal                            14.643 14.641 
Calcium Carbonate                                   0.333 0.333 
Phosphoric Acid                                     0.466 0.466 
Salt 0.067 0.067 
Mineral PX                                          0.166 0.166 
Tallow Edible with VIT E                             13.167 13.166 
Choline Chloride Liquid                             0.236 0.244 
Pyridoxine HCL PF                                   0.012 
Astaxanthin 
Fuji Powder 2%  
(ASTAREAL PZ AF)         
 0.012 
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Table 2.  Mean (±SEM) values for body weight (kg), body mass index (kg/ m²), girth (cm), 
energy intake (kcal/kg), and total fat (%) in 20 cats (n=20, 10 males and 10 females) at different 
% body weight increases.  There was no difference between the two diet groups and the results 
were combined.  Values with the same superscript letter differ significantly (all p < 0.001). 
 
 Weight (kg) BMI (kg/m²) Girth (cm) Energy intake 
(kcal/kg) 
Total Fat % 
0% 3.4±0.2a 32.4±1.1d 30.2±0.7g 40.6±1.1j 25±1m,n 
10% 3.9±0.2a,b 36.9±1.3d,e 35.3±1g,h 52.9±1j,k  
30% 4.4±0.2b,c 42.4±1.5e,f 38.6±0.8h,i 59.7±1.1k,l 45±2 m,o 
60% 5.7±0.3c 54.7±2.1f 45.2±0.8i 64.4±1.8l 57±2n,o  
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Table 3.  Mean (±SEM) baseline (mg/dL) and AUC (g/dL per 180min) concentrations of glucose 
in 20 cats (n=20, 10 males and 10 females) at different % body weight increases.  Values with 
the same superscript differ significantly (a p < 0.0331).   
 
 0% 10% 30% 60% 
Baseline 89.2±3.5 88.7±1.7 88.8±1.4 87.4±2.2 
Diet C AUC 23±0.8 22.7±0.6 23.9±1.1 24.7±0.7 
Diet AOX AUC 21.2±1.5 23±0.6 23.6±0.5a 25.6±1.2a 
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Table 4.  Mean (±SEM) baseline (pmol/L) and AUC (nmol/L per 180min) concentrations of 
insulin in 20 cats (n=20, 10 males and 10 females) at different % body weight increases.  The 
insulin secretion pattern did not differ significantly between the two diet groups and the results 
were combined.  Values with the same superscript letter differ significantly (a,b,c,d,e,f p < 0.024), 
(g,h,i,j,k,l p < 0.001), (m,n,o,p p < 0.025), (q,r,s,t,u p < 0.043) 
 
 0% 10% 30% 60% 
Baseline  31.8±4.9a,b,c,m 58.1±7.8a,d,e 85.7±12.6b,d,f,n,o 111.9±17.1c,e,f,p 
120min 
concentration 
31.8±3.6q 43.4±5.1q 55.2±6.6n,t 93.1±17t 
180min 
concentration 
25.3±2.5m,r 39.3±4.6r,s 49.4±6.6o,s,u 80.6±10.5p,u 
AUC  14.9±1.2g,h,i 17.2±1.7g,j,k 21.1±2.4h,j,l 28.5±3.7i,k,l 
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Table 5.  Mean (±SEM) baseline (mg/dL) and AUC concentrations (g/dL per 360min) of 
cholesterol, triglyceride, and HDL, and baseline non-esterified fatty acids (NEFA; mEq/L) in 20 
cats (n=20, 10 males and 10 females) at different % body weight increases.  The cholesterol, 
triglyceride, and HDL concentrations were not significantly different between the two diet 
groups and the results were combined.  Values with the same superscript letter differ 
significantly (all p < 0.023). 
 
 0% 10% 30% 60% 
Baseline 
Cholesterol 
150±10 140±7 142±9 135±9 
AUC 
Cholesterol 
52.8±3.7 47.2±2.5 49.9±3.4 47.8±3 
Baseline  
Triglyceride 
18±2a,b,c 33±4a,d 44±10b 67±12c,d 
AUC HDL 44.8±1.4 40.1±1.8 43±1.7 41.2±1.7 
NEFA 0.63+0.05e,f 0.72+0.10 0.85+0.04e 0.88+0.08f 
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Table 6.  Mean (±SEM) catalase (Units/mg Hb), glutathione peroxidase (Gpx) (Units/mg Hb) 
and red blood cell superoxide dismutase (SOD RBC) activity (Units/g Hb) in 20 cats (n=20, 10 
males and 10 females) at different % body weight increases.  The enzyme activities were not 
significantly different between the two diet groups and the results were combined.  There was no 
significant difference among the cats with increasing body weight.   
 
 0% 10% 30% 60% 
Catalase  210±29 219±26 177±20 187±28 
Gpx  97±5 102±5 99±3 97±4 
SOD RBC  3124±394 4332±263 2231±191 2735±360 
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Table 7.  Mean (±SEM) baseline (Units/ml) and AUC (Units/ml per 15min) concentrations of 
heparin releasable superoxide dismutase (SOD) activity in 20 cats (n=20, 10 males and 10 
females) at different % body weight increases.  The baseline and AUC concentrations of plasma 
SOD were not significantly different between the two diet groups and the results were combined.  
There was no significant difference among the cats with increasing body weight.    
   
 0% 10% 30% 60% 
Baseline  5.8±0.9 5.7±0.6 5.8±1.1 6±1.1 
AUC 3779±875 1722±319 2305±465 3731±1056 
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Table 8.  Mean (±SEM) values for IL-6 (ng/ml), IL-1 (ng/ml), and TNF-Alpha (ng/ml) 
concentrations in 20 cats (n=20, 10 males and 10 females) at different % body weight increases.  
The IL-1, IL-6, and TNF-Alpha concentrations were not significantly different between the two 
diet groups and the results were combined.  There was no significant difference among the cats 
with increasing body weight.   
 
 0% 10% 30% 60% 
IL-6  2822±981 2022±544 2111±452 2593±597 
IL-1  2689±835 2686±839 2318±632 2325±710 
TNF-Alpha  1390±281 1364±328 1353±303 1237±211 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 44 
Table 9.  Mean (±SEM) values for baseline respiratory exchange ratio and heat production 
(kcal/kg0.75) per 24 h in 20 cats (n=20, 10 males and 10 females) at different % body weight 
increases.  Values with the same superscript letter differ significantly (a p < 0.008), (b p < 0.002), 
(d p < 0.0237), (e p < 0.0001), (f p < 0.0001), (g p < 0.0006), (h p < 0.001), and (i p < 0.0070). 
 
 0% 10% 30% 60% 
RER 0.7698±0.006a,b 0.7832±0.005 0.7989±0.003a 0.7903±0.006b 
Heat 54.7±1.7d,e,f 59.9±1.2d,g,h 66.7±1.3e,g,i 70.7±1.9f,h,i 
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Figure 2.  Relationship between total fat mass and body mass index (BMI); A, body weight; B 
and girth; C in 20 cats (n=20, 10 males and 10 females) at 0% and after 10, 30, and 60% body 
weight increase. 
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Figure 3.  Relationship between body mass index (BMI) and body weight; A, and girth; B and 
relationship between girth and body weight; C in 20 cats (n=20, 10 males and 10 females) at 0% 
and after 10, 30, and 60% body weight increase. 
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Figure 4.  Relationship between food intake and body mass index (BMI); A, body weight; B and 
girth; C in 20 cats (n=20, 10 males and 10 females) at 0% and after 10, 30, and 60% body weight 
increase. 
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Figure 5.  Insulin secretion pattern following a bolus of glucose in 20 cats (n=20, 10 males and 
10 females) at 0% and after 10, 30, and 60% body weight increase. 
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Figure 6.  Relationship between baseline insulin concentrations and body mass index (BMI); A, 
body weight; B and girth; C in 20 cats (n=20, 10 males and 10 females) at 0% and after 10, 30, 
and 60% body weight increase. 
 
 
. 
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Figure 7.  Relationship between insulin area under the curve (AUC) and body mass index (BMI); 
A, body weight; B and girth; C in 20 cats (n=20, 10 males and 10 females) at 0% and after 10, 
30, and 60% body weight increase. 
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Chapter 5 Summary and Conclusions 
      The purpose of this research was to examine if an increase in fat mass was associated with an 
increased inflammatory response and oxidative stress, leading to insulin resistance and abnormal 
insulin secretion.  The effect of antioxidants on oxidative stress was also assessed with 
increasing fat mass.    
Body Weight, BMI, Girth, Energy Intake, and Total Fat 
   As % body weight increased, BMI, total fat mass, and girth increased significantly.  Percent 
total body fat correlated best with girth, suggesting that girth is a good indicator for measuring 
fat mass when DEXA and MRI are unavailable.  The increase in body weight correlated well 
with an increase in food intake.   
Glucose and Insulin    
   We have previously shown, when comparing obese cats with lean cats, that an increase in body 
weight by 1 kg leads to a decrease in insulin sensitivity by approximately 30%.  However, a 
longitudinal study examining the insulin changes has not been performed to our knowledge.  The 
lack of change in baseline glucose concentrations is likely due to the fact that obese cats can 
down-regulate hepatic glucose output (Kley et al 2009).  However, AUC for glucose, although 
unchanged up to 30% body weight increase was significantly higher at 60% body weight 
increase in cats fed AOX, indicating glucose intolerance.  A significant decrease was seen in 
insulin sensitivity with increasing body weight.  Baseline insulin concentrations and total AUC 
increased significantly with increasing body weight, BMI and girth indicating insulin resistance 
even at a 10% body weight increase.   
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Lipid Analysis 
   Triglycerides increased significantly with increasing body weight, indicating a possible 
increase in VLDL, the major triglyceride carrier.  NEFAs also increased; this suggests lower 
lipoprotein lipase and higher hormone sensitive lipase concentrations.   
Enzyme Assays 
   We did not see any significant change in catalase, glutathione peroxidase, or SOD enzyme 
activity in RBCs or in heparin releasable SOD in plasma, not supporting our hypothesis that 
increased obesity would be associated with an increase in oxidative stress.   
Cytokines 
   We saw no significant change in plasma IL-6, IL-1, and TNF-alpha with increasing body 
weight, not supporting a generalized inflammatory  response to the increase in body weight.    
Indirect Calorimetry 
   The RER increased significantly at 30 and 60% body weight increase, indicating a decrease in 
fat oxidation.  Our results show a significant increase in heat production with increasing weight, 
indicating increased energy production, likely due to the increase in food intake.   
Conclusions 
 
   An increase in obesity does not elicit a systemic inflammatory response in cats, despite the fact 
that it leads to insulin resistance even at a 10% body weight increase.  These results may in part 
explain the fact that obese cats do no exhibit signs of the metabolic syndrome including 
atherosclerosis and hypertension.   
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